(Total Views: 685)
Posted On: 04/03/2018 1:51:10 PM
Post# of 6903
$DTHR Sales Target: Dthera expects to reach 5,000 subscriptions within the first five months after launch, with well-leveraged customer acquisition cost (CAC) to long term customer value ratio (LTV).
National Exchange Uplisting: The Company intends to up-list to a national exchange by the end of 2018.
Pipeline Growth: Dthera intends to pursue additional uses for ReminX, as well as other medically effective therapies that will be delivered over the Dthera Delivery Platform.
About Digital Therapeutics
Digital therapeutics, a new and emerging subsection of digital health, are technologies that deliver a therapy directly to a patient via a digital interface. The sector offers the promise of scaling effective individual therapies to larger patient populations, thereby amplifying care, changing patient behavior, and reducing the cost-of-care.
https://finance.yahoo.com/news/uipath-set-hos...00309.html
National Exchange Uplisting: The Company intends to up-list to a national exchange by the end of 2018.
Pipeline Growth: Dthera intends to pursue additional uses for ReminX, as well as other medically effective therapies that will be delivered over the Dthera Delivery Platform.
About Digital Therapeutics
Digital therapeutics, a new and emerging subsection of digital health, are technologies that deliver a therapy directly to a patient via a digital interface. The sector offers the promise of scaling effective individual therapies to larger patient populations, thereby amplifying care, changing patient behavior, and reducing the cost-of-care.
https://finance.yahoo.com/news/uipath-set-hos...00309.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
